SEC Filings | EyePoint Pharmaceuticals

Form	Description	Filing date	View
SC 13D/A	An amendment to a SC 13D filing	Dec 08, 2023	View HTML 0001193125-23-291815.pdf 0001193125-23-291815.rtf 0001193125-23-291815.xls
424B5	Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3	Dec 07, 2023	View HTML 0001193125-23-290270.pdf 0001193125-23-290270.rtf 0001193125-23-290270.xls
4	Statement of changes in beneficial ownership of securities	Dec 07, 2023	View HTML 0001562180-23-008222.pdf 0001562180-23-008222.rtf 0001562180-23-008222.xls
4	Statement of changes in beneficial ownership of securities	Dec 07, 2023	View HTML 0001840315-23-000007.pdf 0001840315-23-000007.rtf 0001840315-23-000007.xls
4	Statement of changes in beneficial ownership of securities	Dec 06, 2023	View HTML 0000929638-23-003383.pdf 0000929638-23-003383.rtf 0000929638-23-003383.xls
3	Initial filing by director officer or owner of more than ten percent	Dec 06, 2023	View HTML 0000929638-23-003382.pdf 0000929638-23-003382.rtf 0000929638-23-003382.xls
4	Statement of changes in beneficial ownership of securities	Dec 06, 2023	View HTML 0001562180-23-008172.pdf 0001562180-23-008172.rtf 0001562180-23-008172.xls
4	Statement of changes in beneficial ownership of securities	Dec 06, 2023	View HTML 0001562180-23-008171.pdf 0001562180-23-008171.rtf 0001562180-23-008171.xls
4	Statement of changes in beneficial ownership of securities	Dec 06, 2023	View HTML 0001562180-23-008170.pdf 0001562180-23-008170.rtf 0001562180-23-008170.xls
144	Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing	Dec 05, 2023	View HTML 0001840315-23-000006.pdf 0001840315-23-000006.rtf

Data provided by Kaleidoscope.